Primary Language, Income and the Intensification of Anti-glycemic Medications in Managed Care: the (TRIAD) Study
Primary Language, Income and the Intensification of Anti-glycemic Medications in Managed Care: the (TRIAD) Study
复制标题
DOI:
10.1007/s11606-010-1588-2
复制
发表时间:
2011-05-01
影响因子:
5.7
通讯作者:
Mangione, Carol M.
中科院分区:
文献类型:
--
作者:
Duru, O. Kenrik;Bilik, Dori;Mangione, Carol M.
Patients who speak Spanish and/or have low socioeconomic status are at greater risk of suboptimal glycemic control. Inadequate intensification of anti-glycemic medications may partially explain this disparity.To examine the associations between primary language, income, and medication intensification.Cohort study with 18-month follow-up.One thousand nine hundred and thirty-nine patients with Type 2 diabetes who were not using insulin enrolled in the Translating Research into Action for Diabetes Study (TRIAD), a study of diabetes care in managed care.Using administrative pharmacy data, we compared the odds of medication intensification for patients with baseline A1c a parts per thousand yenaEuro parts per thousand 8%, by primary language and annual income. Covariates included age, sex, race/ethnicity, education, Charlson score, diabetes duration, baseline A1c, type of diabetes treatment, and health plan.Overall, 42.4% of patients were taking intensified regimens at the time of follow-up. We found no difference in the odds of intensification for English speakers versus Spanish speakers. However, compared to patients with incomes $75,000 (OR 2.22, 1.53-3.24) had increased odds of intensification. This latter pattern did not differ statistically by race.Low-income patients were less likely to receive medication intensification compared to higher-income patients, but primary language (Spanish vs. English) was not associated with differences in intensification in a managed care setting. Future studies are needed to explain the reduced rate of intensification among low income patients in managed care.